top of page
Investment opportunity
Join Us in Revolutionizing Immunization
IP-driven business model
Licensing / acquisition strategy
Seeking €2M
Use: R&D + IP acquisition
Building next-gen mRNA vaccine platform
Let’s Work Together
Get in touch so we can start working together.
bottom of page